Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Barrett

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Molecular Therapy Oncolytics|March 27, 2023
Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcomaChelsae R Watters, Oumar Barro, Natalie M Elliott, et al.
Frontiers in Oncology|September 18, 2015
Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi AnemiaJingying Xu, Ashley Sloane Margol, Anju Shukla, et al.
Breast Cancer Research : BCR|July 13, 2018
The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancersMichael T Barrett, Elizabeth Lenkiewicz, Smriti Malasi, et al.
Oncotarget|August 29, 2015
Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancerMichael T Barrett, Karen S Anderson, Elizabeth Lenkiewicz, et al.
The Journal of Pathology|February 5, 2011
Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancerChristian Ruiz, David R Holz, Martin Oeggerli, et al.
Genome Medicine|February 4, 2014
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinomaLisa Evers, Pedro A Perez-Mancera, Elizabeth Lenkiewicz, et al.
Scientific Reports|January 12, 2023
PDJ amplicon in triple negative breast cancerAlexander S Roesler, Smriti Malasi, Lori Koslosky, et al.
British Journal of Cancer|July 20, 2017
Clinical study of genomic drivers in pancreatic ductal adenocarcinomaMichael T Barrett, Ray Deiotte, Elizabeth Lenkiewicz, et al.
Molecular Therapy. Oncology|March 24, 2025
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinomaChelsae R Watters, Oumar Barro, Musa Gabere, et al.
The Oncologist|January 23, 2025
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreductionVincent Chung, Angela Alistar, Carlos Becerra, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Molecular Therapy Oncolytics|March 27, 2023
Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcomaChelsae R Watters, Oumar Barro, Natalie M Elliott, et al.
Frontiers in Oncology|September 18, 2015
Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi AnemiaJingying Xu, Ashley Sloane Margol, Anju Shukla, et al.
Breast Cancer Research : BCR|July 13, 2018
The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancersMichael T Barrett, Elizabeth Lenkiewicz, Smriti Malasi, et al.
Oncotarget|August 29, 2015
Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancerMichael T Barrett, Karen S Anderson, Elizabeth Lenkiewicz, et al.
The Journal of Pathology|February 5, 2011
Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancerChristian Ruiz, David R Holz, Martin Oeggerli, et al.
Genome Medicine|February 4, 2014
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinomaLisa Evers, Pedro A Perez-Mancera, Elizabeth Lenkiewicz, et al.
Scientific Reports|January 12, 2023
PDJ amplicon in triple negative breast cancerAlexander S Roesler, Smriti Malasi, Lori Koslosky, et al.
British Journal of Cancer|July 20, 2017
Clinical study of genomic drivers in pancreatic ductal adenocarcinomaMichael T Barrett, Ray Deiotte, Elizabeth Lenkiewicz, et al.
Molecular Therapy. Oncology|March 24, 2025
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinomaChelsae R Watters, Oumar Barro, Musa Gabere, et al.
The Oncologist|January 23, 2025
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreductionVincent Chung, Angela Alistar, Carlos Becerra, et al.
Pageof 7